Galactosyltransferases modify carbohydrate chains that are attached to glycoproteins, proteoglycans, and glycolipids. Seven putative C. elegans genes have sequence motifs indicative of -1,3-galactosyltransferase function. Through an RNAi screen, one of these genes, Y110A2AL.14, was found to be required for early embryonic development. Sequence similarities using the BLAST program suggest that Y110A2AL.14 is a C. elegans homolog to human Galactosyltransferase II (GalT2) in the proteoglycan biosynthesis pathway. This cDNA encodes a type II membrane protein of 330 amino acids, shows 57 % amino acid similarity to human GalT2 and contains a DXD sequence motif that is potentially critical for enzymatic activity. A recombinant GalT2 fusion protein was expressed in insect cells and was purified to homogeneity. In vitro enzyme assays are consistent with this protein having GalT2 function. Glycosyltransferase activity was specific for galactose, utilizing the sugar donor UDP-galactose, and the acceptor, a terminal -linked galactose residue. We conclude that C. elegans Y110A2AL.14 encodes the enzyme likely act to attach the third sugar in the tetrasaccharide linker (GlcA--1,3-Gal--1,3-Gal--1,4-Xyl--1-O-Serine) for glycosaminoglaycan attachment. Glycosaminoglycan chains like heparan sulfate, chondroitin sulfate and dermatin sulfate inpact many properties of cells and require this tetrasaccharide for attachment. Therefore, reduction of C. elegans GalT II levels using RNAi, indicate that embryonic development depends on the expression of glycosaminoglycans. The RNAi knock-down phenotype is stronger in the F2 generation, suggesting that GalT2 is a maternal protein stored in oocytes at the time of fertilization. High yields of purified recombinant GalT2 has allowed us to produce single-chain anti-GalT2 antibodies to localize GalT2 in developing oocytes, embryos and larva. Y110A2AL.14 has recently been identified as
sqv-2 by Hwang, Olson, Brown, Esko and Horvitz (JBC, in press)